Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varinder Jeet

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|August 20, 2016
MicroRNA Theranostics in Prostate Cancer Precision MedicineFarhana Matin, Varinder Jeet, Judith A Clements, et al.
Pharmacoeconomics|November 15, 2024
Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in AustraliaQunfei Chen, Martin Hoyle, Varinder Jeet, et al.
Clinical Chemistry|May 19, 2019
Emergence of MicroRNAs as Key Players in Cancer Cell MetabolismSugarniya Subramaniam, Varinder Jeet, Judith A Clements, et al.
Social Science & Medicine (1982)|March 13, 2023
Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic reviewAntonio Ahumada-Canale, Varinder Jeet, Anam Bilgrami, et al.
The Prostate|February 6, 2008
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancerVarinder Jeet, Kim Ow, Eboney Doherty, et al.
Scientific Reports|April 29, 2018
A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate CancerFarhana Matin, Varinder Jeet, Leire Moya, et al.
Clinical Chemistry|April 26, 2019
MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate CancerFarhana Matin, Varinder Jeet, Srilakshmi Srinivasan, et al.
Cancer Letters|February 9, 2025
Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancerSugarniya Subramaniam, Varinder Jeet, Jennifer H Gunter, et al.
European Journal of Immunology|November 7, 2015
Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsetsMeng-Chieh Chiang, Kirsteen M Tullett, Yoke Seng Lee, et al.
Molecular and Cellular Endocrinology|October 27, 2015
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancerGregor Tevz, Sean McGrath, Ryan Demeter, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|August 20, 2016
MicroRNA Theranostics in Prostate Cancer Precision MedicineFarhana Matin, Varinder Jeet, Judith A Clements, et al.
Pharmacoeconomics|November 15, 2024
Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in AustraliaQunfei Chen, Martin Hoyle, Varinder Jeet, et al.
Clinical Chemistry|May 19, 2019
Emergence of MicroRNAs as Key Players in Cancer Cell MetabolismSugarniya Subramaniam, Varinder Jeet, Judith A Clements, et al.
Social Science & Medicine (1982)|March 13, 2023
Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic reviewAntonio Ahumada-Canale, Varinder Jeet, Anam Bilgrami, et al.
The Prostate|February 6, 2008
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancerVarinder Jeet, Kim Ow, Eboney Doherty, et al.
Scientific Reports|April 29, 2018
A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate CancerFarhana Matin, Varinder Jeet, Leire Moya, et al.
Clinical Chemistry|April 26, 2019
MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate CancerFarhana Matin, Varinder Jeet, Srilakshmi Srinivasan, et al.
Cancer Letters|February 9, 2025
Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancerSugarniya Subramaniam, Varinder Jeet, Jennifer H Gunter, et al.
European Journal of Immunology|November 7, 2015
Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsetsMeng-Chieh Chiang, Kirsteen M Tullett, Yoke Seng Lee, et al.
Molecular and Cellular Endocrinology|October 27, 2015
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancerGregor Tevz, Sean McGrath, Ryan Demeter, et al.
Pageof 3